中国抗体-B
港股通 官网
( 03681.hk)
市盈率-5.55市净率4.11市销率554.53股息率0.00%上市时间2019-11-12股价1.12港币 (-4.27% , 91.73万港币) 市值12.23亿港币总股本10.92亿上市至今年化投资收益率-27.95%
所属三级行业生物技术 (恒生) 市盈率-49.59市净率2.75市销率5.16股息率0.63%
备注 (0): 双击编辑备注
发表讨论

中国抗体-B(03681) - 历史董事名单

# 姓名职衔职位委任日期辞任日期
1張健民Non Executive Director2023-09-06--
2石磊Non Executive Director2021-12-17--
3劉潔Non Executive Director2021-12-142023-09-06
4李志明Independent Non Executive Director2021-06-15--
5強靜Non Executive Director2020-11-302021-12-14
6CAUTHERLEY George William HunterIndependent Non Executive Director2019-12-23--
7董汛Non Executive Director2019-12-23--
8強靜Executive Director2019-12-232020-11-30
9韓炳祖Independent Non Executive Director - A/F2019-10-18--
10TINKER Dylan CarloIndependent Non Executive Director2019-10-18--
11何灝勤Independent Non Executive Director2019-10-182021-06-15
12馬慧淵Non Executive Director2019-04-292021-12-14
13劉暢Non Executive Director2019-04-292019-12-23
14劉森林Non Executive Director2019-02-152022-06-13
15陳海剛Non Executive Director2017-08-31--
16劉文溢Non Executive Director2017-08-31--
17梁瑞安Executive DirectorChairman, CEO2001-04-27--